A Phase I/II, multiple-dose, dose-escalation study to assess the Safety, Efficacy and Pharmacokinetics of Intravenous CNTO 328 and Anti-Interleukin 6 (IL-6) Monoclonal Antibody, in subjects with Solid Tumours.

Project Details

Short titleA Phase I/II, multiple-dose, dose-escalation study to assess the Safety, Efficacy and Pharmacokinetics of Intravenous CNTO 328 and Anti-Interleukin 6 (IL-6) Monoclonal Antibody, in subjects with Solid Tumours.
StatusFinished
Effective start/end date15/11/09 → 31/12/12

Funding

  • Queen Elizabeth Hospital